These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20211180)

  • 1. Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C.
    Fontana RJ; Sanyal AJ; Ghany MG; Lee WM; Reid AE; Naishadham D; Everson GT; Kahn JA; Di Bisceglie AM; Szabo G; Morgan TR; Everhart JE;
    Gastroenterology; 2010 Jun; 138(7):2321-31, 2331.e1-2. PubMed ID: 20211180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
    Fontana RJ; Sanyal AJ; Ghany MG; Bonkovsky HL; Morgan TR; Litman HJ; Reid AE; Lee WM; Naishadham D;
    Am J Gastroenterol; 2011 May; 106(5):884-93. PubMed ID: 21139575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.
    Sanyal AJ; Fontana RJ; Di Bisceglie AM; Everhart JE; Doherty MC; Everson GT; Donovan JA; Malet PF; Mehta S; Sheikh MY; Reid AE; Ghany MG; Gretch DR; Halt-C Trial Group
    Gastrointest Endosc; 2006 Dec; 64(6):855-64. PubMed ID: 17140886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
    Fontana RJ; Dienstag JL; Bonkovsky HL; Sterling RK; Naishadham D; Goodman ZD; Lok AS; Wright EC; Su GL;
    Gut; 2010 Oct; 59(10):1401-9. PubMed ID: 20675691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy.
    D'Ambrosio R; Aghemo A; Rumi MG; Primignani M; Dell'Era A; Lampertico P; Donato MF; De Nicola S; Prati GM; de Franchis R; Colombo M
    Antivir Ther; 2011; 16(5):677-84. PubMed ID: 21817189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and progression of gastroesophageal varices in patients with chronic hepatitis C.
    Gentile I; Borgia G
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):867-70. PubMed ID: 20695740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of betablocked patients after sustained virological response in hepatitis C cirrhosis.
    Abadía M; Montes ML; Ponce D; Froilán C; Romero M; Poza J; Hernández T; Fernández-Martos R; Olveira A;
    World J Gastroenterol; 2019 Jun; 25(21):2665-2674. PubMed ID: 31210717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
    Lok AS; Everhart JE; Chung RT; Kim HY; Everson GT; Hoefs JC; Greenson JK; Sterling RK; Lindsay KL; Lee WM; Di Bisceglie AM; Bonkovsky HL; Ghany MG; Morishima C;
    Hepatology; 2009 Jun; 49(6):1828-37. PubMed ID: 19291787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
    Shiffman ML; Morishima C; Dienstag JL; Lindsay KL; Hoefs JC; Lee WM; Wright EC; Naishadham D; Everson GT; Lok AS; Di Bisceglie AM; Bonkovsky HL; Ghany MG;
    Gastroenterology; 2009 Dec; 137(6):1986-94. PubMed ID: 19747918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
    Lok AS; Everhart JE; Wright EC; Di Bisceglie AM; Kim HY; Sterling RK; Everson GT; Lindsay KL; Lee WM; Bonkovsky HL; Dienstag JL; Ghany MG; Morishima C; Morgan TR;
    Gastroenterology; 2011 Mar; 140(3):840-9; quiz e12. PubMed ID: 21129375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C.
    García-Samaniego J; Romero M; Granados R; Alemán R; Jorge Juan M; Suárez D; Pérez R; Castellano G; González-Portela C
    World J Gastroenterol; 2013 Mar; 19(12):1943-52. PubMed ID: 23569340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
    Dienstag JL; Ghany MG; Morgan TR; Di Bisceglie AM; Bonkovsky HL; Kim HY; Seeff LB; Szabo G; Wright EC; Sterling RK; Everson GT; Lindsay KL; Lee WM; Lok AS; Morishima C; Stoddard AM; Everhart JE;
    Hepatology; 2011 Aug; 54(2):396-405. PubMed ID: 21520194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
    Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.
    Freedman ND; Curto TM; Lindsay KL; Wright EC; Sinha R; Everhart JE;
    Gastroenterology; 2011 Jun; 140(7):1961-9. PubMed ID: 21376050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis C.
    Fontana RJ; Bieliauskas LA; Back-Madruga C; Lindsay KL; Litman HJ; Lok AS; Kronfol Z;
    Am J Gastroenterol; 2010 Jul; 105(7):1551-60. PubMed ID: 20104219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis.
    Gentile I; Viola C; Graf M; Liuzzi R; Quarto M; Cerini R; Piazza M; Borgia G
    J Clin Gastroenterol; 2009 Jan; 43(1):81-7. PubMed ID: 18562980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of liver and spleen stiffness measured by fibroscan® in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals.
    Muñoz-Codoceo C; Amo M; Martín A; Martín-Arriscado Arroba C; Cuevas Del Campo L; Manzano ML; Muñoz R; Castellano G; Fernández I
    Gastroenterol Hepatol; 2021 Apr; 44(4):269-276. PubMed ID: 33097282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease.
    Ma JL; He LL; Jiang Y; Yang JR; Li P; Zang Y; Wei HS
    Ann Hepatol; 2020; 19(3):287-294. PubMed ID: 32197976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices.
    Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.